Q2B25 Paris | Stefan  Ostermann, Quantum Applications Manager, QuEra Computing Inc @QCWare
Q2B25 Paris | Stefan  Ostermann, Quantum Applications Manager, QuEra Computing Inc  @QCWare
Uploaded October 2025 | Updated September 2026, 2 weeks ago
Beyond Classical Limits: Quantum’s Role in Future Drug Development -- Establishing Neutral Atoms as a Platform for Pharmaceutical Innovation:

I will present efforts toward applying quantum computing to drug design, highlighting approaches that integrate quantum algorithms with pharmaceutical R&D workflows. Particular focus will be given to where neutral-atom quantum computers may provide unique value. The talk will outline both near-term opportunities and long-term directions for utilizing quantum computers in the pharmaceutical domain.

q2b.qcware.com
Q2B25 Paris | Stefan  Ostermann, Quantum Applications Manager, QuEra Computing IncQ2B25 Paris | Loic Le Loarer, Head of Quantum, SGPIQ2B26 Tokyo | Daisuke Tanaka, CEO, Quanmatic Inc.Q2B25 Silicon Valley | Matt Johnson, CEO, QC Ware Corp.Q2B25 Paris | Fabio Beltram, National Quantum Science and Technology InstituteQ2B25 Paris | Bruno Sanglé Ferriere, CEO, Carrousel Digital
QC Ware |

Q2B25 Paris | Stefan Ostermann, Quantum Applications Manager, QuEra Computing Inc

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER